Enterprise CTMS platforms were designed for companies with dedicated IT teams, 12-month implementation budgets, and global trial portfolios. You need something that is live in weeks and does not require a consultant to operate.
1 AE flagged — Site 3 · Auto-escalated
Six Core Capabilities
Upload once. Syncs to all sites automatically. Every amendment distributes in minutes.
Each site sees only their patients and data. Sponsor sees everything. Role-based access at every level.
Real-time AE reporting with automated escalation workflows. Full 21 CFR Part 11 audit trail.
Placebo integrity maintained automatically. System enforces blinding rules — no accidental unblinding.
Real-time funnel: identified → pre-screened → consented → enrolled → active. No spreadsheet check-ins.
Data sovereignty requirements? Hekma deploys inside your VPC. Your data never leaves your environment.
Deployment Models
| Deployment Model | Timeline | Infrastructure |
|---|---|---|
| SaaS | Live in 3–5 business days | Hekma-hosted |
| VPC / Private Cloud | Live in 4–8 weeks | Customer's cloud (AWS / GCP / Azure) |
| On-Premises | 8–16 weeks | Customer's own hardware |
What This Replaces
60% of SMB pharma companies still use spreadsheets and email chains to coordinate their first trials. This is why amendments take days to distribute, why AEs fall through the cracks, and why enrollment visibility requires a Monday morning call with every site. This ends that.
Compliance & Standards
SaaS in 3–5 days. No consultant. No 12-month implementation. Connected to patient recruitment from day one.